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Abstract
Background: The proteasome homeostasis in Saccharomyces cerevisiae is regulated by a negative feedback circuit in which
the transcription factor Rpn4 induces the proteasome genes and is rapidly degraded by the assembled proteasome. The
integrity of the Rpn4-proteasome feedback loop is critical for cell viability under stressed conditions. We have demonstrated
that inhibition of Rpn4 degradation sensitizes cells to DNA damage, particularly in response to high doses of DNA damaging
agents. The underlying mechanism, however, remains unclear.
Methodology/Principal Findings: Using yeast genetics and biochemical approach we show that inhibition of Rpn4
degradation displays a synthetic growth defect with deletion of the MEC1 checkpoint gene and sensitizes several
checkpoint mutants to DNA damage. In addition, inhibition of Rpn4 degradation leads to a defect in repair of double-strand
breaks (DSBs) by nonhomologous end-joining (NHEJ). The expression levels of several key NHEJ genes are downregulated
and the recruitment of Yku70 to a DSB is reduced by inhibition of Rpn4 degradation. We find that Rpn4 and the proteasome
are recruited to a DSB, suggesting their direct participation in NHEJ. Inhibition of Rpn4 degradation may result in a
concomitant delay of release of Rpn4 and the proteasome from a DSB.
Conclusion/Significance: This study provides the first evidence for the role of proteasomal degradation of Rpn4 in NHEJ.
Citation: Ju D, Wang X, Ha S-W, Fu J, Xie Y (2010) Inhibition of Proteasomal Degradation of Rpn4 Impairs Nonhomologous End-Joining Repair of DNA Double-
Strand Breaks. PLoS ONE 5(4): e9877. doi:10.1371/journal.pone.0009877
Editor: Maria G. Masucci, Karolinska Institutet, Sweden
Received February 3, 2010; Accepted March 4, 2010; Published April 1, 2010
Copyright:  2010 Ju et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Science Foundation grant MCB-0816974 to YX. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: xiey@karmanos.org
Introduction
The S. cerevisiae RPN4 gene (also named SON1 and UFD5) was
originally isolated as a suppressor of sec63-101, a temperature-
sensitive mutant of SEC63, which encodes an essential component
of the endoplasmic reticulum translocation channel [1,2].
Subsequent work showed that deletion of RPN4 inhibits the
degradation of several model substrates of the N-end rule and
UFD (Ub fusion degradation) pathways, suggesting the involve-
ment of Rpn4 in proteasomal degradation [3]. The exact
functional role of Rpn4 in protein degradation, however,
remained unclear until recent studies revealed that Rpn4 is a
transcription factor for the proteasome genes [4,5]. This finding
explains why the proteasome activity is diminished in an rpn4D
mutant. Interestingly, Rpn4 is an extremely short-lived protein
(t1/2#2 min) and degraded by the proteasome [5–10]. Moreover,
stabilization of Rpn4 by inhibition of the proteasome activity leads
to an increase in the expression levels of the proteasome genes
[11,12]. Together, these observations led to a model in which the
proteasome homeostasis is regulated by a negative feedback
circuit. On the one hand, Rpn4 upregulates the proteasome genes;
on the other hand, Rpn4 is rapidly degraded by the assembled/
active proteasome. The Rpn4-proteasome negative feedback
circuit provides an efficient and sensitive means to control the in
vivo proteasome abundance. The proteasome genes in higher
eukaryotes including humans are regulated by a similar negative
feedback mechanism even though the homologs of Rpn4 have not
yet been identified [13–16].
In addition to the proteasome genes, Rpn4 appears to influence
the expression of a large number of other genes involved in protein
ubiquitylation, DNA repair and other cellular processes [4,17–23].
Interestingly, the promoter of RPN4 carries the binding sites for
heat-shock transcription factor (Hsf1), multidrug resistance-related
transcription factors (Pdr1 and Pdr3), and Yap1, a transcription
factor that plays an important role in response to oxidation and
DNA damage [18,24,25]. These transcription factors are activated
by a variety of environmental stressors and in turn induce RPN4
expression [11,12,17,18,24–26]. These observations suggest that
Rpn4 may serve as a major stress- responsive mediator. The
Rpn4-proteasome negative feedback loop likely plays a central role
in the Rpn4-mediated stress response network, not only by
maintaining the proteasome homeostasis but also by gauging the
expression levels of other Rpn4 target genes through proteasomal
degradation of Rpn4. In support of this hypothesis, our recent
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of the Rpn4-proteasome negative feedback loop, namely Rpn4-
induced proteasome expression and proteasomal degradation of
Rpn4, severely reduces cell viability under stressed conditions
[27,28].
Rpn4 can be degraded by two distinct mechanisms, ubiquitin
(Ub)-dependent and -independent [6]. Our recent studies showed
that the N-terminal 10 amino acids are required for the Ub-
independent degradation of Rpn4, whereas residues 211–229
constitute the Ub-dependent degradation signal [6–10]. Simulta-
neous deletions of residues 1–10 and 211–229 substantially
stabilize Rpn4, and yet, do not impair its transcriptional activity
[28,29]. Taking advantage of this stabilized Rpn4 mutant
(Rpn4D1–10/D211–229, referred to as Rpn4* for abbreviation), we
demonstrated that inhibition of Rpn4 degradation causes cell
hypersensitivity to DNA damage, particularly in response to high
doses of DNA damaging agents [28]. It is possible that expression
of Rpn4* may affect checkpoint activation in response to DNA
damage. Alternatively, it may lead to a defect in DNA repair.
In this study we sought to understand how inhibition of Rpn4
degradation sensitizes cells to DNA damage. We found that
expression of Rpn4*, while imposing no effect on DNA checkpoint
activation, displays a synthetic growth defect with deletion of the
MEC1 checkpoint gene and sensitizes several checkpoint mutants
to DNA damage. We further demonstrated that expression of
Rpn4* impairs NHEJ but not homologous recombination (HR)
repair of DSBs. The expression levels of several key NHEJ genes
are downregulated and the recruitment of Yku70 to a DSB is
reduced in the cells expressing Rpn4*. Interestingly, Rpn4 is
recruited to a DSB and inhibition of Rpn4 degradation may cause
a concomitant delay of the dissociation of Rpn4 and the
proteasome from the DSB. These observations suggest that
inhibition of Rpn4 degradation may affect NHEJ through different
mechanisms.
Results
Inhibition of Rpn4 degradation does not affect
checkpoint activation
To examine whether expression of Rpn4* could affect DNA
checkpoint activation, we compared the phosphorylation of Rad53
in response to MMS between the cells expressing wildtype Rpn4
or Rpn4*. Rad53 is a central transducer of DNA damage
responses in S. cerevisiae and its phosphorylation is a hallmark of
checkpoint activation [30,31]. A plasmid encoding C-terminally
FLAG-tagged Rad53 was co-transformed with low-copy vectors
expressing RPN4 or RPN4* from the native RPN4 promoter into
an rpn4D strain. The transformants were treated with MMS and
cell extracts were prepared at different time points. The
phosphorylated and unphosphorylated Rad53 species were
separated by SDS-PAGE and detected by immunoblotting
analysis with an anti-FLAG antibody. As shown in Figure 1A,
the kinetics of Rad53 phosphorylation in response to the MMS
treatment was similar between the cells expressing RPN4 or
RPN4*. Thus, inhibition of Rpn4 degradation does not impair
checkpoint activation in response to DNA damage.
Synergistic effects caused by inhibition of Rpn4
degradation and checkpoint mutations
We then wondered if inhibition of Rpn4 degradation could
display a synthetic growth defect with DNA checkpoint mutations.
We decided to measure the synthetic effect of deletion of MEC1
and expression of Rpn4* since Mec1 is the major checkpoint
protein in S. cerevisiae [19,31–33]. Low-copy plasmids expressing
RPN4 or RPN4* were transformed into a mec1D mutant and an
isogenic MEC1 strain. Note that the SML1 gene has been deleted
in these two strains to suppress the lethality of single deletion of
MEC1 [30]. Whereas Rpn4* showed only a mild effect on the
sml1D control strain, it markedly slowed the growth of the mec1D
sml1D mutant (Figure 1B). This analysis demonstrated that
inhibition of Rpn4 degradation and a defect in DNA checkpoint
activation can cause a synthetic negative effect on cell growth.
We went on to examine whether expression of Rpn4* could
exacerbate the sensitivity of checkpoint mutants to DNA
damaging agents. To this end, we transformed the RPN4* and
RPN4 plasmids into the mec1D sml1D mutant. The isogenic sml1D
strain was used as a wildtype control. The transformants were
treated with 0.01% MMS for 0, 1, 2, 3 and 4 h, and the survival
rates were measured by the colony formation assay. Although
Rpn4* only had a marginal effect on the wildtype strain under this
low dose MMS stress, it reduced the survival rate of the mec1D
mutant by ,10 fold after 4 h treatment (Figure 1C). We also
tested the effect of Rpn4* on two other checkpoint mutants, tof1D
and tel1D, using a similar assay except that the MMS
concentration was increased to 0.03%. Tof1 is a subunit of the
Tof1-Mrc1-Csm3 checkpoint complex, which acts at the stalled
replication fork [34–36]. Tel1 is the yeast homolog of the human
ataxia telangiectasia (ATM) checkpoint protein, primarily involved
in telomere length regulation [37,38]. As shown in Figure 1D,
Rpn4* enhanced the sensitivity of tof1D and tel1D mutants to
MMS. Thus, expression of Rpn4*, while not directly affecting
checkpoint activation, reduces the viability of checkpoint mutants
in response to DNA damage, suggesting that inhibition of Rpn4
degradation may affect DNA repair.
Inhibition of Rpn4 degradation impedes DSB repair by
NHEJ
Our early study showed that the effect of Rpn4* on cell viability
became increasingly prominent when cells were treated with high
doses of DNA damaging agents [28], suggesting that degradation
of Rpn4 may be important for repairing severely damaged DNA,
i.e. DSBs. To test this conjecture, we decided to examine whether
expression of Rpn4* leads to a defect in either HR or NHEJ repair
of a single DSB induced by the HO endonuclease. Specifically, we
used the haploid yeast strain YFP17, which expresses the HO
endonuclease from the GAL10 promoter and carries an HO
recognition site in the leu2 locus on chromosome III [39]. The
native HO cut sites at the MAT, HML, and HMR loci have been
deleted in this strain. Therefore, a single DSB is created at the leu2
locus in this donor-less strain upon HO induction by galactose. To
measure the effect of Rpn4* on HR efficiency, we replaced the
RPN4 open reading frame (ORF) on chromosome IV with a LEU2
selection marker, which can serve as a homologous template for
HR repair of the DSB at the leu2 locus (Figure 2A). Low-copy
vectors expressing RPN4* or RPN4 from the native RPN4
promoter or a void vector were transformed into the rpn4D::LEU2
strain. The relative survival rates of the transformants on galactose
versus glucose plates, which reflect the efficiency of DSB repair by
HR, were measured by the colony formation assay. As shown in
Figure 2B, the RPN4* strain had a similar relative survival rate as
the wildtype RPN4 strain, suggesting that inhibition of Rpn4
degradation has no significant effect on HR. In contrast, the
relative survival rate of the rpn4D strain was only ,50% of that of
the wildtype strain, indicating that Rpn4 is important for HR. In
line with this observation, we found that it was generally less
efficient to generate site-specific recombinant strains from an
rpn4D background strain than from its wildtype counterpart (data
not shown).
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strain was constructed by replacing the rpn4D::LEU2 allele with an
RPN4*::TRP1 cassette via site-specific recombination (Figure 2C).
A triple ha tag (3ha) was added to the C-terminus of Rpn4* for
immunoprecipitation analysis with an anti-ha antibody. To create
a control strain, we inserted a C-terminal 3ha tag and a TRP1
selection marker at the RPN4 locus in the parental YFP17 strain.
An rpn4D::TRP1 strain was also generated by replacing the RPN4
ORF of YFP17 with a TRP1 selection marker to assess the
requirement of Rpn4 in NHEJ. The relative survival rates of these
three strains on galactose versus glucose plates were measured by
the colony formation assay. Because of the lack of HR template in
these strains, growth on galactose plates depends on NHEJ. As
shown in Figure 2D, the survival rate of RPN4* cells was 6–7 fold
lower than that of their wildtype counterparts. Introduction of an
exogenous RPN4* plasmid into the wildtype cells also dramatically
reduced their viability on galactose plates (Figure 2D). These
results imply that inhibition of Rpn4 degradation may impair
NHEJ. Deletion of RPN4 also affected NHEJ, but to a much
smaller extent compared to expression of Rpn4* (Figure 2D).
To further examine the effect of Rpn4* on NHEJ, we decided to
compare the kinetics of DSB repair by NHEJ between the
wildtype and RPN4* strains. We first monitored the appearance of
HO-induced DSB. Specifically, genomic DNA was prepared from
cell cultures withdrawn at different time points after galactose
induction and analyzed by quantitative real-time PCR (qRT-PCR)
using a pair of primers (P1 and P2) flanking the HO cut site
(Figure 3A). A decrease in the yield of PCR product is expected
after the chromosome is broken. Another pair of primers
amplifying an unrelated gene was used as a control to normalize
the qRT-PCR results. We found that the kinetics of DSB
formation was similar between the wildtype and RPN4* strains
(Figure 3B). The percentage of cells with a DSB was slightly but
reproducibly higher in the RPN4* strain than in its wildtype
counterpart. This difference likely reflects more efficient early
repair (in competition with HO cutting) in the wildtype strain
relative to the RPN4* strain. Since more than 80% of cells have
acquired a DSB after 60 min of galactose induction, we decided to
terminate HO expression at 60 min by transferring the cell
cultures into glucose medium to follow DSB repair. Chromatin
fractions were prepared at different time points and subjected to
qRT-PCR analysis with primers P1 and P2. As shown in
Figure 3C, the wildtype cells repaired the DSB more efficiently
than their RPN4* counterparts after termination of HO expres-
sion. Together, these results demonstrate that inhibition of Rpn4
degradation impairs NHEJ.
Figure 1. Synergistic effects caused by inhibition of Rpn4 degradation and checkpoint mutations. (A) Inhibition of Rpn4 degradation
does not affect Rad53 phosphorylation. Cells expressing C-terminally FLAG-tagged Rad53 with either Rpn4 or Rpn4* were treated with 0.1% MMS and
cell extracts were prepared at different time points and subjected to SDS-PAGE (6% gel), followed by immunoblotting with an anti-FLAG antibody
(upper panel). The membrane was reprobed with an anti-a tubulin antibody to compare the loading (lower panel). Phosphorylated and
unphosphorylated species of Rad53 were marked. An asterisk indicated a cross-reactive band with the anti-FLAG antibody. (B) A synthetic growth
defect caused by inhibition of Rpn4 degradation and deletion of MEC1. The growth of sml1D and sml1D mec1D cells expressing either Rpn4 or Rpn4*
was assessed by a five-fold serial dilution assay. (C, D) Inhibition of Rpn4 degradation sensitizes checkpoint mutants mec1D (C), tof1D and tel1D (D) to
MMS. The colony formation assay was used to measure the survival rates, which are expressed as a percentage of the value of untreated cells set at
100%. The data shown are the mean of at least three independent experiments with deviation less than 10%.
doi:10.1371/journal.pone.0009877.g001
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To gain insights into the NHEJ defect caused by inhibition of
Rpn4 degradation, we compared the expression levels of all the
genes known to be related to NHEJ between the wildtype and
RPN4* strains by qRT-PCR analysis. Forty-one genes were
analyzed (see Table S1), including the structural/catalytic NHEJ
components (MRE11, RAD50, XRS2, YKU70, YKU80, DNL4,
LIF1, and NEJ1) and those whose mutations lead to partial defects
in NHEJ [40–49]. We found that the expression levels of MRE11,
YKU70, YKU80, NEJ1, and INO80 were lower in the RPN4* strain
than in the wildtype strain (Figure 4A). In contrast, RTT109,
RAD27, SWC5, and BRE5 were expressed at a higher level in the
RPN4* strain than in the wildtype strain. The expression levels of
other NHEJ genes were comparable between these two strains
(data not shown). Interestingly, there is a 10-bp consensus
sequence in the promoters of YKU70, YKU80, and NEJ1
(Figure 4B), suggesting that these three genes may be coordinately
downregulated in the presence of Rpn4*.
Reduced recruitment of Yku70 to a DSB in the RPN4*
strain
The downregulation of YKU70 and YKU80 in the RPN4* strain
prompted us to examine if the recruitment of the Ku complex to a
DSB is affected by expression of Rpn4*. To this end, we attached
a triple FLAG tag (3FLAG) to the C-terminus of Yku70 expressed
from its chromosomal locus in the wildtype and RPN4* strains.
Note that addition of the 3FLAG tag to Yku70 did not affect the
cell’s NHEJ efficiency (data not shown). The binding of Yku70 to
the DSB was determined by the chromatin immunoprecipitation
(ChIP) assay. Based on the kinetics of DSB formation in galactose
Figure 2. Inhibition of Rpn4 degradation leads to a defect in NHEJ. (A) An experimental system to measure HR. The RPN4 ORF on
chromosome IV of the YFP17 strain was replaced with a LEU2 selection marker, which also serves as a homologous template for HR repair of the HO-
cut DSB at leu2 on chromosome III. (B) Rpn4* has no significant effect on HR. Low-copy vectors expressing RPN4 or RPN4* from the native RPN4
promoter or a void vector were transformed into the rpn4D::LEU2 strain in (A). The resulting transformants were spread on galactose and glucose
plates. Survival rates were expressed as the ratios of colony counts on galactose plates to those on glucose plates. (C) Construction of an RPN4* strain.
The rpn4D::LEU2 allele of the rpn4D::LEU2 strain was replaced with an RPN4*-3ha::TRP1 cassette via site-specific recombination (see Materials and
Methods). 59-UTR represents the RPN4 promoter region whereas the boxes in gray are the homologous sequences between the pRS304 and pRS305
backbones. (D) Rpn4* impedes NHEJ. Wildtype, RPN4* and rpn4D strains and a wildtype transformant with an exogenous RPN4* plasmid were spread
on galactose and glucose plates. Survival rates were calculated by dividing the colony numbers on galactose plates by those on glucose plates. Data
represented are the mean of three independent experiments.
doi:10.1371/journal.pone.0009877.g002
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immunoprecipitated with Yku70 by an anti-FLAG antibody at
different time points. Two pairs of primers were used for qRT-
PCR to quantitate the recovered DNA by ChIP, with one
corresponding to the proximal side and the other on the distal side
of the HO cut site (Figure 5A). We found that Yku70 was recruited
immediately following the formation of DSB in both wildtype and
RPN4* strains, peaking at ,90 min (Figure 5B). However, the
initial recruitment of Yku70, i.e. at 30 min, was apparently slower
in the RPN4* strain compared to that in the wildtype strain. In
addition, the ChIP signals were generally weaker in the RPN4*
strain than in the wildtype strain. The reduced recruitment of
Yku70 to the DSB is in line with the downregulation of YKU70 in
the RPN4* strain.
Concomitantly delayed dissociation of Rpn4* and the
proteasome from a DSB
Whereas the effect of Rpn4* on NHEJ may be attributed to the
deregulation of some NHEJ genes, we suspected that Rpn4 might
affect NHEJ via other routes. This thought originated from the
observations that Rpn4 interacts with the proteasome and that the
proteasome directly participates in NHEJ [5,42,50]. We, there-
fore, examined if Rpn4 could be recruited to a DSB, and if so, is
there any difference in the kinetics of recruitment and dissociation
of Rpn4 and Rpn4* to and from the DSB. Taking advantage of
the 3ha tag attached to the C-termini of Rpn4 and Rpn4* in the
wildtype and RPN4* strains, we were able to use an anti-ha
antibody to perform the ChIP assay. Cells were grown in galactose
medium to induce DSB formation, followed by transfer to glucose
medium to terminate HO expression. Aliquot samples were
withdrawn at different time points during galactose induction and
after termination of HO induction to measure the Rpn4 and
Rpn4* ChIP signals by qRT-PCR. This assay showed that both
Rpn4 and Rpn4* were recruited to the DSB (Figure 6A). Whereas
a modestly larger amount of Rpn4* was recruited to the DSB than
Rpn4, probably due to a higher steady-state level of Rpn4*, the
kinetics of recruitment was quite similar between Rpn4 and
Rpn4*, both peaking 30 min after HO shut-off (Figure 6A).
Interestingly, the Rpn4 ChIP signal rapidly decreased after
approaching the peak. In contrast, the maximal Rpn4* ChIP
signal persisted for almost 60 min before it began to decline. These
results suggest that inhibition of Rpn4 degradation may delay the
dissociation of Rpn4 from the DSB.
We then tested if Rpn4* could affect the binding and
dissociation of the proteasome to and from a DBS. For the ChIP
analysis, a 3FLAG tag was added to the C-terminus of the Pre6
proteasome subunit expressed from its chromosomal locus.
Although relatively stronger Pre6 ChIP signals were recorded in
the RPN4* strain than in the wildtype strain, likely resulting from
upregulation of Pre6 in the RPN4* strain [28], the kinetics of Pre6
Figure 3. The kinetics of NHEJ is slower in the RPN4* strain. (A)
Positions of the primers (P1 and P2) used for DSB analysis. (B)
Measurement of DSB induction. Genomic DNA was prepared from
wildtype and RPN4* strains at different time points of galactose
induction and analyzed by qRT-PCR. The extent of DSB induction was
determined by the ratio of PCR product from primers P1 and P2 to that
from a pair of control primers amplifying an unrelated gene (PRE1). (C)
Slower NHEJ in the RPN4* strain. Wildtype and RPN4* cells were induced
by galactose for 1 h, followed by transfer to glucose medium to
terminate HO expression. Genomic DNA was prepared at different time
points as indicated, and subjected to qRT-PCR analysis as (B).
doi:10.1371/journal.pone.0009877.g003
Figure 4. Altered expression of NHEJ genes by inhibition of
Rpn4 degradation. (A) The expression levels of NHEJ genes in
wildtype and RPN4* strains were analyzed by qRT-PCR. ACT1 was used
as an internal control. Values were presented as relative ratios to the
mRNA levels in the wildtype strain. Results shown here are the mean of
three independent experiments. (B) A 10-bp consensus sequence
(highlighted in bold) exists in the promoters of YKU70, YKU80, and NEJ1.
doi:10.1371/journal.pone.0009877.g004
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peak 30 min after termination of HO induction (Figure 6B). Thus,
Rpn4* does not appear to affect the initial binding of the
proteasome to the DSB. This assay also suggested that Rpn4 and
the proteasome may be recruited simultaneously to the DSB
because the binding of Rpn4 and Pre6 to the DSB followed a
similar kinetics. Interestingly, the dissociation of Pre6 from the
DSB was apparently slower in the RPN4* strain than the wildtype
strain (Figure 6B). Together, these results imply a concomitant
delay in releasing Rpn4* and the proteasome from the DSB.
Discussion
In this study we demonstrated that inhibition of Rpn4
degradation impairs NHEJ. Our data suggest that this detrimental
effect may involve different mechanisms. One possible mechanism
is that inhibition of Rpn4 degradation alters the expression of
some NHEJ genes. For example, YKU70 is downregulated in the
RPN4* strain, and as a consequence, the recruitment of Yku70 to a
DSB is reduced. Several other core (structural and/or catalytic)
NHEJ genes, including MRE11, YKU80, and NEJ1, are also
downregulated in the presence of Rpn4*. Interestingly, there is a
10-bp consensus sequence in the promoters of YKU70, YKU80,
and NEJ1 genes, suggesting that they may be coordinately
regulated. We suspect that the effect of Rpn4* on the expression
of these three genes may be indirect as no Rpn4 binding site is
found in their promoters. It is possible that inhibition of Rpn4
degradation may lead to upregulation of a repressor, perhaps
encoded by an Rpn4 target gene, which binds to the 10-bp
consensus sequence and represses the NHEJ genes. In addition to
the core NHEJ genes, the expression of INO80, which encodes a
subunit of the INO80 chromatin remodeling complex that has
been shown to play a role in NHEJ [44,45], is downregulated in
the RPN4* strain. This may also contribute to the NHEJ defect
caused by inhibition of Rpn4 degradation. Interestingly, inhibition
of Rpn4 degradation leads to upregulation of several NHEJ-
related genes, including RTT109, which encodes a histone
acetyltransferase that acetylates H3-K56 [51]. We found that
overexpression of RTT109 partially impaired NHEJ (data not
Figure 5. Inhibition of Rpn4 degradation reduces the recruit-
ment of Yku70 to a DSB. (A) Two sets of primers, proximal (P3/P4)
and distal (P5/P6) to the HO cut site, were used in the ChIP assay. (B)
The kinetics of Yku70 recruitment to a DSB in the wildtype and RPN4*
strains. Cell extracts were prepared from samples collected at different
time points after galactose induction and subjected to ChIP as
described in Materials and Methods. Specific binding of Yku70 to the
DSB was expressed as a ratio of the PCR product from immunoprecip-
itated DNA to input DNA, and normalized against the nonspecific ChIP
signal obtained from the sample before HO induction (time zero), which
was set at 1.0. Both ChIP results using the proximal (upper panel) and
distal (lower panel) sets of primers were shown. The values are the
mean of three independent experiments.
doi:10.1371/journal.pone.0009877.g005
Figure 6. Delayed release of Rpn4* and the proteasome from a
DSB in the RPN4* strain. Wildtype and RPN4* strains in which a
3FLAG tag was added to the C-terminus of Pre6 were induced by
galactose for 1 h, and then transferred to glucose medium to terminate
HO expression. Samples were prepared at different time points for ChIP
analysis with an anti-ha antibody for Rpn4-3ha and Rpn4*-3ha (A) or an
anti-FLAG antibody for Pre6-3FLAG (B). The binding of Rpn4, Rpn4* or
Pre1 to the DSB was expressed as a ratio of the PCR product from
immunoprecipitated DNA to input DNA, and normalized against the
nonspecific ChIP signal obtained from the sample at time zero (before
HO induction), which was set at 1.0. Shown here are the qRT-PCR results
with primers P3 and P4. Data are presented as the mean of three
independent experiments. Similar results were obtained using primers
P5 and P6 (data not shown).
doi:10.1371/journal.pone.0009877.g006
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showing that Rtt109 is required for efficient NHEJ [43]. Perhaps,
an appropriate expression level of Rtt109 is critical for NHEJ. Too
much or too little Rtt109 would decrease the NHEJ efficiency.
Inhibition of Rpn4 degradation may affect NHEJ through another
mechanism. We showed that Rpn4 is recruited to a DSB, suggesting
that Rpn4 may directly participate in NHEJ. Interestingly, whereas
their recruiting kinetics is similar, the release of Rpn4* from the DSB
is markedly slower than that of Rpn4. This implies that release of
Rpn4 from the DSB, perhaps through proteasomal degradation, may
be important for NHEJ. It is worthy of note that proteasome
dissociation from the DSB is concomitantly delayed with Rpn4* in
the RPN4* strain. This observation suggests that Rpn4 and the
proteasome may cooperate in NHEJ. Given that Rpn4 is a DNA-
binding protein and a ligand and a substrate of the proteasome [4,5],
it is tempting to speculate that, on the one hand, Rpn4 assists in
recruiting the proteasome to a DSB, and on the other hand,
degradationofRpn4facilitatesthereleaseoftheproteasomefromthe
DSB. The role of the proteasome in NHEJ is likely to degrade one or
more of the chromatin proteins surrounding the DSB to open up the
space for the entrance of repair proteins. It is also possible that the
proteasome degrades one or more of the repair proteins in the course
of DSB repair. However, the proteasome may block the sequential
recruitment of ‘‘late’’ repair proteins or interfere with the assembly of
NHEJ complexes if its dissociation from the DNA lesion is delayed.
Therefore, removal of the proteasome from a DSB can be critical for
the proceeding of NHEJ. Whereas this model is attractive, we cannot
definitely rule out the possibility that the prolonged association of
Rpn4* on the DSB may be a result of the delay of the NHEJ process
in the RPN4* strain. Further investigation is needed to address this
possibility.We should point out that it remains possiblethat inhibition
of Rpn4 degradation may also affect a post-NHEJ process and
contribute to the reduced cell viability.
It is interesting to note that, while expression of Rpn4* clearly
affects NHEJ, it displays no significant effect on HR. This
observation suggests that proteasomal degradation of Rpn4 may
be specifically required for the cell’s commitment to NHEJ.
Previous studies have shown that HR and NHEJ compete for
DSBs; but the mechanism ruling this competition remains largely
unclear [52,53]. Alternatively, inhibition of Rpn4 degradation
may not alter the expression of HR-related genes as sufficiently as
it does on some of the NHEJ genes, and, therefore, does not affect
HR. We are also aware of the possibility that the RPN4* cells may
lose viability more quickly than wildtype cells in the presence of a
persistent DSB. This difference is somewhat insignificant in the
presence of HR, which manages to fix the continuously occurring
DSB before the RPN4* cells lose viability. However, in the absence
of HR, the persistent DSB may not be repaired in time by NHEJ,
which is known less efficient than HR, leading to a lower survival
rate of the RPN4* cells relative to their wildtype counterparts. This
explanation reflects that inhibition of Rpn4 degradation not only
impairs the NHEJ process, but may also make the cells more
vulnerable to a persistent DSB.
Whereas the current study is focused on the biological relevance
of Rpn4 degradation in DSB repair, we found that the RPN4*
strain is hypersensitive to a variety of stressed conditions [28]. It
will be of interest to investigate the functional role of proteasomal
degradation of Rpn4 in other cellular pathways.
Materials and Methods
Yeast strains and plasmids
Yeast strains used in this study were listed in Table 1. Details of
construction of the yeast strains and plasmids are available upon
request. The replacement vector p305rpn4D::LEU2 for deletion of
RPN4 was previously described [3]. It carries 59 and 39 UTR
fragments of RPN4 linked by a Pst1 site in the pRS305 vector. To
switch the selection marker from LEU2 to TRP1, we digested
p305rpn4D::LEU2 with Xho1 and Not1 and subcloned the insert
into Xho1/Not1-cut pRS304 vector to obtain p304rpn4D::TRP1.
Pst1-linearized p304rpn4D::TRP1 and p305rpn4D::LEU2 vectors
weretransformed intoYFP17 toreplace RPN4, resulting inYXY676
(rpn4D::TRP1) and YXY494 (rpn4D::LEU2) strains. Full-length RPN4
and the truncated RPN4D1–10/D211–229 allele (RPN4*, see ref. 28)
were ligated with the RPN4 promoter (,500 bp) into the low-copy
vectors pRS313 and pRS314 [54], resulting in p313RPN4,
p314RPN4, p313RPN4* and p314RPN4* plasmids. For detection
of the Rpn4 and Rpn4* proteins, a DNA sequence encoding a triple
Table 1. S. cerevisiae strains used in this study.
Strains Genotypes Sources/References
EJY140 MATa trp1-D63 ura3-52 his3-D200 leu2-3,112 lys2-801 rpn4D::LEU2 [3]
BY4741 MATa his3-D1 leu2D0 met15D0 ura3D0 [56]
YGB655 MATa his3-D1 leu2D0 met15D0 ura3D0s m l 1 D::NatR A gift from G Brush
YGB656 MATa his3-D1 leu2D0 met15D0 ura3D0s m l 1 D::NatR mec1D::LEU2 A gift from G Brush
tof1D MATa his3-D1 leu2D0 met15D0 ura3D0t o f 1 D::KanR [56]
tel1D MATa his3-D1 leu2D0 met15D0 ura3D0 tel1D::KanR [56]
YFP17 hmlD::ADE1 mataD::hisG hmrD::ADE1 leu2-cs ade3::GAL1::HO ade1 lys5 ura3-52 his4 [39]
YXY494 an rpn4D::LEU2 derivative of YFP17 This study
YXY506 an RPN4-3ha::TRP1 derivative of YFP17 This study
YXY512 an RPN4*-3ha::TRP1 derivative of YXY494 This study
YXY526 a YKU70-3FLAG::URA3 derivative of YXY506 This study
YXY532 a YKU70-3FLAG::URA3 derivative of YXY512 This study
YXY570 a PRE6-3FLAG::URA3 derivative of YXY506 This study
YXY572 a PRE6-3FLAG::URA3 derivative of YXY512 This study
YXY676 an rpn4D::TRP1 derivative of YFP17 This study
doi:10.1371/journal.pone.0009877.t001
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RPN4* in the p314RPN4 and p314RPN4* vectors to obtain
p314RPN4-3ha and p314RPN4*-3ha. p314RPN4-3ha was cut with
Spe1/Sac1andtheinsert(C-terminalfragmentofRPN4plusthe3ha
tag) was subcloned into Spe1/Sac1-cut pRS306 vector to get
p306RPN4DN-3ha. We then cut p306RPN4DN-3ha with Xho1/
Sac1, and subcloned the insert into Xho1/Sac1-cut pRS304 vector
to get p304RPN4DN-3ha. Bgl2-linearized p304RPN4DN-3ha vector
was transformed into YFP17 to generate YXY506 (RPN4-
3ha::TRP1) strain. p314RPN4* was digested with Xho1/EcoR1
andthe1.7 kbinsert(500 bpRPN4promoterplus1.2 kbN-terminal
sequence of RPN4*) was subcloned into Xho1/EcoR1-cut pRS304
vector to get p304RPN4*DC. p314RPN4-3ha was cut with EcoR1/
Sac1 and the insert was subcloned into EcoR1/Sac1-cut
p304RPN4*DC vector to get p304RPN4*-3ha. Xho1-linearized
p304RPN4*-3ha vector was transformed into YXY494 to get
YXY512 (RPN4*-3ha::TRP1) strain. To generate yeast strains for
ChIP analysis,weconstructedauniversal3FLAG-tagged integration
vector. Primers YX771 (TCGACGACTACAAGGACGACGAT-
GACAAGGGCGGAGCCGATTATAAGGATGATGACGACA-
AGGC, bolded are 2 FLAG repeats separated by a linker of Gly-
Gly-Ala) and YX772 (GGCCGCCTTGTCGTCATCATCCT-
TATAATCGGCTCCGCCCTTGTCATCGTCGTCCTTGT-
AGTCG, bolded are 2 FLAG repeats separated by a linker of Gly-
Gly-Ala) were annealed and subcloned into Sal1/Not1-cut 314CU-
Pha-FLAG vector (7) to obtain 314CUPha-3FLAG. We then cut
314CUPha-3FLAG with Xho1/Sac1 and subcloned the insert into
Xho1/Sac1-cut pRS306 vector to get the 306CUPha-3FLAG
vector. We amplified a 770 bp C-terminal fragment of YKU70 with
primers YX779 (ACCGGTACCGTCAAGATCAGATAGTAAT-
GG, italic is a Kpn1 site) and YX780 (CAAGTCGACTATATT-
GAATTTCGGCTTTTT, italic is a Sal1 site). The PCR products
were cut with Kpn1/Sal1 and subcloned into Kpn1/Sal1-cut
306CUPha-3xFLAG to obtain 306YKU70DN-3FLAG. Hind3-
linearized 306YKU70DN-3FLAG vector was transformed into
YX506 and YX512 to get YXY526 (a YKU70-3FLAG::URA3
derivative of YXY506) and YXY532 (a YKU70-3FLAG::URA3
derivative of YXY512). We amplified PRE6 ORF with primers
YX239 (CAGTCTGCAGATGAGTGGTTACGATAGAGCT)
and YX271 (GATCCTCGAGATGGTTAGATTTTTTCTTT-
TTGTC, italic is an Xho1 site). The PCR products were cut with
Kpn1/Xho1 and subcloned into Kpn1/Sal1-cut 306CUPha-
3xFLAG to obtain 306PRE6DN-3FLAG. Bgl2-linearized
306PRE6DN-3FLAG vector was transformed into YX506 and
YX512 to get YXY570 (a PRE6-3FLAG::URA3 derivative of
YXY506) and YXY572 (a PRE6-3FLAG::URA3 derivative of
YXY512). RAD53 ORF without stop codon was amplified by
PCR with primers YX766 (CAAGAATTCATGGAAAATATTA-
CACAACCC, italic is an EcoR1 site) and YX765 (AC-
CAGCGGCCGCCGAAAATTGCAAATTCTCGGG, italic is a
Not1 site). The PCR products were digested with EcoR1/Not1
and subcloned into EcoR1/Not1-cut 314CUPha-FLAG vector to
get 314CUPRAD53FLAG, which expresses C-terminally FLAG-
tagged Rad53 from the CUP1 promoter. All plasmids were verified
by restriction enzyme analysis and DNA sequencing, and desired
yeast strains were confirmed by PCR and immunoblotting analysis.
Immunoblotting analysis
Yeast cells were grown to OD600 of 0.8–1.2, harvested and
resuspended in lysis buffer (150 mM NaCl, 50 mM Tris.Cl, 5 mM
EDTA, 1% Triton X-100, pH 7.5) plus protease inhibitor mix
(Roche, Indianapolis). Yeast extracts were prepared using the
glass-bead vortexing method [11]. Protein concentrations were
measured by Bradford assay. Approximately 20 mg of each extract
was resolved by SDS-PAGE, followed by immunoblotting with an
anti-FLAG antibody for C-terminally FLAG-tagged Rad53, and
detection with the Odyssey infrared imaging system (Li-Cor
Biosciences). The blot was reprobed with an anti-yeast a tubulin
antibody (Chemicon) to verify comparable loading.
Analysis of gene expression
qRT-PCR was applied to measure gene expression. RNA was
prepared from cells grown to OD600 of 0.8–1.2 as previously
described [55]. Reverse-transcription was carried out with
SuperScript II reverse transcriptase (Invitrogen), and qRT-PCR
was performed using Fast SYBR Green Master Mix in the
StepOne
TM system following the manufacturer’s instruction
(Applied Biosystems). The ACT1 gene served as an internal
control for normalization of gene expression levels. The PCR
primers for ACT1 were YX814 (TCCATCCAAGCCGTTTTG)
and YX815 (CGGCCAAATCGATTCTCA), whereas the prim-
ers used for NHEJ genes were listed in Table S1.
Measurement of DSB induction and repair
Overnight cultures were diluted into raffinose medium and
grown to OD600 of ,0.8. Galactose was then added to 2% final
concentration to induce HO endonuclease expression. For DSB
induction analysis, cell samples were withdrawn at various time
points after galactose induction. To measure DSB repair,
galactose-induced cell cultures were transferred to glucose
medium, and cells were collected at different time points after
termination of HO expression. Genomic DNA was prepared from
the cell samples and subjected to qRT-PCR analysis with a pair of
primers (P1 and P2) flanking the HO cut site, which is inside a
117-bp fragment inserted at the leu2 locus of YFP17 and its
derivative strains [39]. P1 (TAGGTGCTGTGGGTGGTC) is
12 bp upstream from the insertion site whereas P2 (TTAG-
TAAACCTTGTTCAGGTC) is 8 bp downstream from the
insertion site. Another pair of primers (YX718, CTCGGATC-
CAAGAAAAGGGAGCACCTG; YX719, CCTTCTAGAAT-
CCTGTACACGGATGCC) amplifying an unrelated gene
(PRE1) were used as control to normalize the qRT-PCR results.
Chromatin immunoprecipitation assay
ChIP assay was carried out as described [27]. In brief, cell
extracts were prepared after in vivo cross-linking of DNA and
proteins with formaldehyde, and incubated with agarose beads
conjugated with anti-FLAG antibody (Sigma) to precipitate Yku70-
3FLAG or Pre6-3FLAG and bound DNA fragments. Or an anti-ha
antibody (Covance) combined with Protein A agarose (Calbiochem)
was used to bring down Rpn4-3ha or Rpn4*-3ha and bound DNA
fragments. After the reversal of cross-links, DNA fragments were
purified and analyzed by qRT-PCR with two sets of primers that
amplified the segments ,40 bp proximal or ,100 bp distal to the
DSB. The proximal primers are P3 (TGTCTGCCCCTAAGAA-
GATCG) and P4 (CAGCCTTCTTGGAGGCTTCCA) whereas
the distal primers are P5 (AGACTTATCTCCAATCAAGCC) and
P6 (GTGATTCTTTGCACTTCTGGA). The ChIP signals were
calculated by normalizing the amount of PCR product from the
immunoprecipitated DNA fragments to that from the input samples
before immunoprecipitation, and expressed as relative ratios against
the nonspecific ChIP signals at time zero (before HO induction) set
at 1.0.
Cell growth and survival assays
Cell growth was assessed by serial dilution assays. Yeast cells
were grown to exponential phase and normalized by optical
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synthetic complete (SC) plates and incubated at 30uC. Cell
survival rates were measured by the colony formation assay. For
MMS stress, overnight cultures were diluted and continued to
grow to OD600 of 0.8,1.2 before subjected to MMS treatment.
Treated cells were extensively washed and seeded on selective SC
plates. Untreated cells were spread on selective SC plates as
control. For HR and NHEJ assays, cells were grown in pre-
induction medium (raffinose medium) and then spread on plates
containing either galactose or glucose. Colonies were counted 3–4
days after plating. Survival rates were measured as the ratios of
colony counts after treatment to the counts without treatment, or
the ratios of colony counts on galactose plates versus those on
glucose plates. Each survival assay was repeated at least 3 times.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0009877.s001 (0.07 MB
DOC)
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